CALLIDITAS THERAPEUTICS
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a co... ncentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.
CALLIDITAS THERAPEUTICS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
1991-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.calliditas.se
Total Employee:
51+
Status:
Active
Contact:
(468)411-3005
Email Addresses:
[email protected]
Total Funding:
108.2 M USD
Technology used in webpage:
Google Maps Google Maps API Cloudmore
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-08-13 | Genkyotex | Genkyotex acquired by Calliditas Therapeutics | 20.3 M USD |
Investors List
Kreos Capital
Kreos Capital investment in Debt Financing - Calliditas Therapeutics
Industrifonden
Industrifonden investment in Series C - Calliditas Therapeutics
Industrifonden
Industrifonden investment in Venture Round - Calliditas Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-06 | Calliditas appoints new Chief Medical Officer |
Official Site Inspections
http://www.calliditas.se Semrush global rank: 2.37 M Semrush visits lastest month: 7.8 K
- Host name: 104.18.23.112
- IP address: 104.18.23.112
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
